CENPH | Centromere protein H | | | | | | Mixed |
CETN3 | Centrin, EF-hand protein, 3 | | | | | | Expressed in all |
CHD1 | Chromodomain helicase DNA binding protein 1 | Enzymes FDA approved drug targets
| | | | | Expressed in all |
CKMT2 | Creatine kinase, mitochondrial 2 (sarcomeric) | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
CLINT1 | Clathrin interactor 1 | Plasma proteins
| | | | | Expressed in all |
CLTB | Clathrin, light chain B | Plasma proteins
| | | | | Expressed in all |
COL4A3BP | Collagen, type IV, alpha 3 (Goodpasture antigen) binding protein | | | | | | Expressed in all |
COX7C | Cytochrome c oxidase subunit VIIc | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CTD-2260A17.2 | Uncharacterized protein | | | | | | Tissue enhanced |
CTNNA1 | Catenin (cadherin-associated protein), alpha 1, 102kDa | Plasma proteins
| | | | | Expressed in all |
CWC27 | CWC27 spliceosome-associated protein homolog (S. cerevisiae) | Enzymes
| | | | | Expressed in all |
CXXC5 | CXXC finger protein 5 | | | | | | Expressed in all |
DAB2 | Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) | Plasma proteins
| | | | | Expressed in all |
DBN1 | Drebrin 1 | Plasma proteins
| | | | | Expressed in all |
DCP2 | Decapping mRNA 2 | Enzymes
| | | | | Expressed in all |
DDX4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | Enzymes
| | | | | Tissue enriched |
DDX41 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 | Enzymes Plasma proteins
| | | | | Expressed in all |
DIMT1 | DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae) | Enzymes
| | | | | Expressed in all |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
DMXL1 | Dmx-like 1 | | | | | | Expressed in all |
DNAH5 | Dynein, axonemal, heavy chain 5 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
DNAJC18 | DnaJ (Hsp40) homolog, subfamily C, member 18 | Predicted membrane proteins
| | | | | Tissue enriched |
DOCK2 | Dedicator of cytokinesis 2 | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Mixed |
DPYSL3 | Dihydropyrimidinase-like 3 | | | | | | Mixed |
DTWD2 | DTW domain containing 2 | | | | | | Mixed |
EFCAB9 | EF-hand calcium binding domain 9 | | | | | | Tissue enriched |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
ELL2 | Elongation factor, RNA polymerase II, 2 | | | | | | Expressed in all |
ELOVL7 | ELOVL fatty acid elongase 7 | Enzymes Predicted membrane proteins
| | | | | Mixed |
ERAP1 | Endoplasmic reticulum aminopeptidase 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ERAP2 | Endoplasmic reticulum aminopeptidase 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ERBB2IP | Erbb2 interacting protein | Cancer-related genes
| | | | | Expressed in all |
ERGIC1 | Endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ETF1 | Eukaryotic translation termination factor 1 | Plasma proteins
| | | | | Expressed in all |
EXOC3 | Exocyst complex component 3 | | | | | | Expressed in all |
F12 | Coagulation factor XII (Hageman factor) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
FABP6 | Fatty acid binding protein 6, ileal | Predicted secreted proteins
| | | | | Tissue enriched |
FAF2 | Fas associated factor family member 2 | Predicted membrane proteins
| | | | | Expressed in all |
FAM114A2 | Family with sequence similarity 114, member A2 | | | | | | Expressed in all |
FAM169A | Family with sequence similarity 169, member A | | | | | | Tissue enhanced |
FAM172A | Family with sequence similarity 172, member A | Predicted secreted proteins
| | | | | Expressed in all |
FAM193B | Family with sequence similarity 193, member B | | | | | | Expressed in all |
FAM71B | Family with sequence similarity 71, member B | | | | | | Tissue enriched |
FAT2 | FAT atypical cadherin 2 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FBN2 | Fibrillin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FBXO38 | F-box protein 38 | Disease related genes
| | | | | Expressed in all |
FCHO2 | FCH domain only 2 | | | | | | Expressed in all |
FER | Fer (fps/fes related) tyrosine kinase | Enzymes Plasma proteins
| | | | | Mixed |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |